Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data-Reference-Cited by-同舟云学术

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

Published:2020-05-01 Issue:5 Volume:15 Page:e0231846
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ohlmeier Christoph^ORCID,Gothe Holger,Haas Judith,Osowski Ulrike,Weinhold Carina,Blauwitz Sarah,Schmedt Niklas,Galetzka Wolfgang,Berkemeier Fabian,Tackenberg Björn,Stangel Martin

Funder

Merck Serono GmbH

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. The epidemiology of multiple sclerosis: insights to disease pathogenesis;DS Goodin;Handb Clin Neurol,2014

2. Defining the clinical course of multiple sclerosis: the 2013 revisions;FD Lublin;Neurology,2014

3. Magnetic resonance monitoring of lesion evolution in multiple sclerosis;A Rovira;Ther Adv Neurol Disord,2013

4. Multiple Sclerosis International Federation (2013) Atlas of MS 2013: Mapping Multiple Sclerosis around the World.

5. Holstiege J, Steffen A, Goffrie B, Bätzing J (2017) Epidemiology of multiple sclerosis—a population-based, Germany-wide study.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells in autoimmune disease: A systematic review and meta-analysis of pre-clinical studies;Biochimie;2024-08

2. Predicting the conversion from clinically isolated syndrome to multiple sclerosis: An explainable machine learning approach;Multiple Sclerosis and Related Disorders;2024-06

3. Characterization and quantification of epilepsy patients with hospital episodes in Portugal;Epilepsy & Behavior;2024-06

4. Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies;Multiple Sclerosis and Related Disorders;2024-05

5. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair;Acta Neuropathologica;2024-04-24